Aligos Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aligos Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aligos Therapeutics Inc
Rating: 1.73425
Author: Trendlyne DVM scores

about

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for no...

11.11 -0.23 (-2.03%)

76.01% Fall from 52W High

55,933

XNAS Volume

XNAS 08 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

18.5 / 100

Technically Neutral

50.9 / 100

1Yr Price target upside is 622%

4 analysts

Aligos Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aligos Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for no...

76.01% Fall from 52W High

SWOT Analysis

Aligos Therapeutics Inc Live Price Chart